Pfizer Inc at SVB Leerink Global Healthcare (Virtual) Transcript
Great. Good afternoon, everyone, and thank you so much for joining us for a discussion with Pfizer's hospital leadership team. It's very much my pleasure to welcome Angela Lukin, who is the Global President of Pfizer Hospital; Annaliesa Anderson, who is the Chief Scientific Officer of the Hospital Group and is also in charge of Bacterial Vaccines; and Jim Rusnak, who is Chief Development Officer for Hospital and also for Internal Medicine. We also have with us Chris Stevo, who is the Chief IR Officer for Pfizer.
And once again, I wanted to thank the participants and for the Pfizer leadership team members for joining us today.
Questions & Answers
I thought it would be great to kick off at a high level, Angela, by asking about the pivot from defense to offense. I mean, clearly, your business has largely resolved its manufacturing issues. And it would be great for you to set the stage for the vision for the Hospital segment.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
